Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Zenas BioPharma, Inc.(ZBIO) | 3,919,159 | 2,919,159 | -1,000,000 | $99.47M | $78.73M | 28.14% | -$20.74M |
| Immunome, Inc.(IMNM) | 3,613,799 | 3,613,799 | 0 | $76.58M | $77.73M | 27.79% | +$1.16M |
| Braveheart Bio Inc | 0 | 3,674,656 | +3,674,656 | $0 | $74.23M | 26.53% | +$74.23M |
| Sionna Therapeutics Inc | 2,478,030 | 2,478,030 | 0 | $109.01M | $13.03M | 4.66% | -$95.97M |
| Upstream Bio Inc | 2,459,703 | 2,459,703 | 0 | $17.02M | $12.96M | 4.63% | -$4.06M |
| Bridgebio Oncology Therapeut | 2,626,946 | 2,626,946 | 0 | $20.02M | $10.77M | 3.85% | -$9.25M |
| Compass Therapeutics Inc | 7,788,150 | 7,788,150 | 0 | $17.06M | $8.10M | 2.90% | -$8.96M |
| Camp4 Therapeutics Corp | 1,425,541 | 1,041,127 | -384,414 | $6.23M | $4.21M | 1.50% | -$2.02M |